Allarity Therapeutics (ALLR) Prepaid Assets (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Prepaid Assets came in at $108000.0 in Q1 2026, down 78.09% YoY from $493000.0 in Q1 2025, and down 59.25% on a QoQ basis from $265000.0 in Q4 2025.
Allarity Therapeutics (ALLR) Prepaid Assets (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Prepaid Assets data on file, last reported at $108000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 78.09% year-over-year to $108000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $108000.0 (down 78.09% YoY) and the FY2025 annual result came in at $265000.0, up 130.43% from the prior year.
- Prepaid Assets declined to $108000.0 in Q1 2026, from $265000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.4 million in Q2 2025 to a low of $108000.0 in Q1 2026.
- A 5-year average of $443529.4 and a median of $265000.0 in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 465.38% — and 2024, when it sank 85.33%.
- Tracing ALLR's Prepaid Assets over 5 years: stood at $591000.0 in 2022, then plunged by 64.64% to $209000.0 in 2023, then slumped by 44.98% to $115000.0 in 2024, then jumped by 130.43% to $265000.0 in 2025, then plunged by 59.25% to $108000.0 in 2026.
- The last three Prepaid Assets figures came in at $108000.0 (Q1 2026), $265000.0 (Q4 2025), and $113000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 265,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 493,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Jun 30, 2024 | 366,000.00 |
| Mar 31, 2024 | 542,000.00 |
| Dec 31, 2023 | 209,000.00 |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 220,000.00 |
| Mar 31, 2023 | 315,000.00 |
| Dec 31, 2022 | 591,000.00 |
| Sep 30, 2022 | 182,000.00 |
| Jun 30, 2022 | 235,000.00 |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 625,000.00 |
| Sep 30, 2021 | 125,000.00 |
| Dec 31, 2020 | 335,000.00 |